SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001070081-20-000104
Filing Date
2020-05-28
Accepted
2020-05-27 19:09:08
Documents
7
Effectiveness Date
2020-05-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2020proxynoticevirtualmee.htm DEFA14A 34733
2 annualmeetingchangepress001.jpg GRAPHIC 204683
3 annualmeetingchangepress002.jpg GRAPHIC 32958
4 ptcnotice001.jpg GRAPHIC 94008
5 ptcnotice002.jpg GRAPHIC 124490
6 ptcnotice003.jpg GRAPHIC 52043
7 ptcnotice004.jpg GRAPHIC 85695
  Complete submission text file 0001070081-20-000104.txt   854101
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35969 | Film No.: 20916613
SIC: 2834 Pharmaceutical Preparations